Portal de Periódicos da CAPES

The role of vaccines in reducing antimicrobial resistance: A review of potential impact of vaccines on AMR and insights across 16 vaccines and pathogens

2024; Elsevier BV; Volume: 42; Issue: 19 Linguagem: Inglês

10.1016/j.vaccine.2024.06.017

1873-2518

Mateusz Hasso-Agopsowicz, Erin Sparrow, Alexandra Meagan Cameron, Hatim Sati, Padmini Srikantiah, Sami L. Gottlieb, Adwoa Bentsi-Enchill, Kirsty Le Doaré, Mary J. Hamel, Birgitte Giersing, William P. Hausdorff,

Vaccine Coverage and Hesitancy

In 2019, an estimated 4.95 million deaths were linked to antimicrobial resistance (AMR). Vaccines can prevent many of these deaths by averting both drug-sensitive and resistant infections, reducing antibiotic usage, and lowering the likelihood of developing resistance genes. However, their role in mitigating AMR is currently underutilized. This article builds upon previous research that utilizes Vaccine Value Profiles—tools that assess the health, socioeconomic, and societal impact of pathogens—to inform vaccine development. We analyze the effects of 16 pathogens, covered by Vaccine Value Profiles, on AMR, and explore how vaccines could reduce AMR. The article also provides insights into vaccine development and usage. Vaccines are crucial in lessening the impact of infectious diseases and curbing the development of AMR. To fully realize their potential, vaccines must be more prominently featured in the overall strategy to combat AMR. This requires ongoing investment in research and development of new vaccines and the implementation of additional prevention and control measures to address this global threat effectively.